Autolus Therapeutics (AUTL) Free Cash Flow (2017 - 2025)
Historic Free Cash Flow for Autolus Therapeutics (AUTL) over the last 9 years, with Q3 2025 value amounting to -$72.3 million.
- Autolus Therapeutics' Free Cash Flow rose 1624.25% to -$72.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$285.2 million, marking a year-over-year decrease of 3871.84%. This contributed to the annual value of -$228.3 million for FY2024, which is 4584.0% down from last year.
- According to the latest figures from Q3 2025, Autolus Therapeutics' Free Cash Flow is -$72.3 million, which was up 1624.25% from -$80.1 million recorded in Q2 2025.
- In the past 5 years, Autolus Therapeutics' Free Cash Flow ranged from a high of -$15.2 million in Q4 2022 and a low of -$86.3 million during Q3 2024
- Moreover, its 5-year median value for Free Cash Flow was -$41.7 million (2023), whereas its average is -$45.8 million.
- Its Free Cash Flow has fluctuated over the past 5 years, first skyrocketed by 5101.32% in 2021, then plummeted by 10709.35% in 2024.
- Quarter analysis of 5 years shows Autolus Therapeutics' Free Cash Flow stood at -$25.3 million in 2021, then soared by 39.89% to -$15.2 million in 2022, then tumbled by 73.1% to -$26.3 million in 2023, then tumbled by 86.42% to -$49.0 million in 2024, then plummeted by 47.43% to -$72.3 million in 2025.
- Its Free Cash Flow stands at -$72.3 million for Q3 2025, versus -$80.1 million for Q2 2025 and -$83.8 million for Q1 2025.